Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC
Clinical trial NCT06672133 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06672133
- Sponsor
- Jinming Yu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2029-06-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.